The two sides will focus on four main areas. First of all, it is necessary to build a model of a Typical Treatment Center, including developing a model for blood fat management for patients with coronary artery syndrome and expanding the application of new therapies in heart failure, dyslipidemia, cancer, criminology and kidneology.
At the same time, continuing medical training programs (CME), scientific seminars and specialized training courses will be promoted to improve the capacity of the medical team.
Regarding clinical research, the cooperation helps Dr. Novartis access international therapies of Novartis earlier, especially in lupus-related nephritis, systemic scleroderma, IgA kidney disease, cardiovascular - metabolic and int most damaged x-rays of axital spinal arthritis.
Finally, the two units will increase programs for patients such as online consultation, health education and support for side effects management, helping patients be more proactive in the treatment process.
